Evaxion AS (EVAX)
3.36
+0.05
(+1.51%)
USD |
NASDAQ |
Aug 24, 16:00
3.21
-0.15
(-4.46%)
After-Hours: 20:00
Evaxion Price to Book Value : 2.940 for Aug. 24, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| August 21, 2026 | 2.896 |
| August 20, 2026 | 2.870 |
| August 19, 2026 | 2.756 |
| August 18, 2026 | 2.756 |
| August 17, 2026 | 2.739 |
| August 14, 2026 | 2.923 |
| August 13, 2026 | 2.810 |
| August 12, 2026 | 2.686 |
| August 11, 2026 | 2.678 |
| August 10, 2026 | 2.669 |
| August 07, 2026 | 2.713 |
| August 06, 2026 | 2.621 |
| August 05, 2026 | 2.608 |
| August 04, 2026 | 2.582 |
| August 03, 2026 | 2.441 |
| July 31, 2026 | 2.468 |
| July 30, 2026 | 2.476 |
| July 29, 2026 | 2.485 |
| July 28, 2026 | 2.450 |
| July 27, 2026 | 2.529 |
| July 24, 2026 | 2.590 |
| July 23, 2026 | 2.669 |
| July 22, 2026 | 2.660 |
| July 21, 2026 | 2.643 |
| July 20, 2026 | 2.573 |
| Date | Value |
|---|---|
| July 17, 2026 | 2.691 |
| July 16, 2026 | 2.730 |
| July 15, 2026 | 2.669 |
| July 14, 2026 | 2.652 |
| July 13, 2026 | 2.643 |
| July 10, 2026 | 2.774 |
| July 09, 2026 | 2.800 |
| July 08, 2026 | 2.844 |
| July 07, 2026 | 2.896 |
| July 06, 2026 | 2.958 |
| July 02, 2026 | 2.984 |
| July 01, 2026 | 2.800 |
| June 30, 2026 | 2.713 |
| June 29, 2026 | 2.021 |
| June 26, 2026 | 1.951 |
| June 25, 2026 | 1.983 |
| June 24, 2026 | 2.134 |
| June 23, 2026 | 2.141 |
| June 22, 2026 | 2.160 |
| June 18, 2026 | 1.926 |
| June 17, 2026 | 2.097 |
| June 16, 2026 | 2.160 |
| June 15, 2026 | 2.273 |
| June 12, 2026 | 2.299 |
| June 11, 2026 | 2.280 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Autolus Therapeutics Plc | 11.13 |
| Cellectis SA | 7.871 |
| Akari Therapeutics Plc | 0.7078 |
| DBV Technologies SA | 4.000 |
| argenx SE | -- |
Price to Book Value Related Metrics
| PS Ratio | 3.341 |
| Price | 3.36 |
| Earnings Yield | -31.36% |
| Market Cap | 28.02M |